Perry Andrew

CIK 00018777931 companyRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001877793

Recent Transactions

20 trades

Disposition to Issuer
G1 Therapeutics, Inc.
Common Stock
2024-09-18−114,482→ 14,232 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−67,050→ 0 total
Disposition from Tender
G1 Therapeutics, Inc.
Common Stock
2024-09-18−14,232→ 0 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-09-18+16,100→ 128,714 total
Disposition to Issuer
G1 Therapeutics, Inc.
Stock Option (right to buy)
2024-09-18−32,100→ 0 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-07-05$2.51/sh−1,337→ 112,614 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-07-01+35,000→ 113,951 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-05-13$4.79/sh−8,151→ 78,951 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2024-01-03+67,050→ 67,050 total
Award
G1 Therapeutics, Inc.
Common Stock
2024-01-03+33,570→ 89,515 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−2,034→ 87,102 total
Sale
G1 Therapeutics, Inc.
Common Stock
2024-01-03$3.12/sh−379→ 89,136 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-07-05$2.45/sh−355→ 55,945 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-05-10+35,000→ 56,300 total
Sale
G1 Therapeutics, Inc.
Common Stock
2023-01-04$5.58/sh−820→ 21,300 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2023-01-03+32,100→ 32,100 total
Award
G1 Therapeutics, Inc.
Common Stock
2023-01-03+16,100→ 22,120 total
Award
G1 Therapeutics, Inc.
Common Stock
2022-01-03+6,000→ 6,020 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2022-01-03+26,500→ 26,500 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to buy)
2021-08-16+300,000→ 300,000 total

Companies

G1 Therapeutics, Inc.
Chief Commercial Officer

Recent Filings

Address

700 PARK OFFICES DRIVE, SUITE 200

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov